NEVINE AWAD: Open Payments
NPI 1427440148 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 15 payments from 8 companies in 2025. Trend: 2023 $173 · 2024 $684 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $155 |
| Novo Nordisk Inc | 4 | $73 |
| KYOWA KIRIN, INC. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| Eisai Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Mannkind Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: UBRELVY, Ozempic, CRYSVITA, OTEZLA, Leqembi, LINZESS, GVOKE HYPOPEN, QULIPTA.
Industry payments across NJ — which companies pay providers there.
